Leadership Overview
Probiotec has 4 executives leading key functions including strategy, finance, operations, and human resources.
Driven by a commitment to innovation and quality, Probiotec excels in manufacturing, marketing, and distributing pharmaceuticals and complementary medicines, serving blue-chip manufacturers and FMCG clients with advanced facilities and experienced personnel.
Driven by a commitment to innovation and quality, Probiotec excels in manufacturing, marketing, and distributing pharmaceuticals and complementary medicines, serving blue-chip manufacturers and FMCG clients with advanced facilities and experienced personnel.
Leadership Roles at Probiotec
Westley Stringer - Chief Executive Officer
Westley Stringer, the Chief Executive Officer at Probiotec, directs the overarching corporate strategy and market positioning for the Australian-based pharmaceutical and complementary medicines company. Stringer guides Probiotec's expansion in contract manufacturing and packaging services, ensuring alignment with the company's commitment to innovation and quality across its diverse client base, which includes food, personal care, and pharmaceutical sectors. This leadership role involves overseeing the strategic direction of subsidiaries like Probiotec Pharma and Probiotec Multipack, ensuring their specialized services in manufacturing and secondary packing for consumer goods meet stringent industry standards. By focusing on high-quality solutions, Westley Stringer drives the company's engagement with blue-chip manufacturers and FMCG clients, leveraging advanced facilities and experienced personnel to maintain Probiotec's competitive edge in the market. The Chief Executive Officer's vision is central to Probiotec's continued growth and its reputation for excellence in the Australian market.
Jared Stringer - Chief Financial Officer
Jared Stringer, the Chief Financial Officer at Probiotec, manages all financial operations and fiscal strategy for the Melbourne-based manufacturer and distributor. Stringer oversees financial planning, budgeting, and reporting, ensuring robust fiscal health and supporting Probiotec's growth initiatives in prescription and over-the-counter pharmaceuticals and complementary medicines. This executive ensures capital allocation aligns with strategic objectives, particularly for contract manufacturing and packaging services catering to food, personal care, and pharmaceutical industries. Jared Stringer's responsibilities include managing investor relations and securing funding to support the company's advanced facilities and experienced personnel. The Chief Financial Officer plays a critical part in evaluating new market opportunities and acquisitions, ensuring financial viability and maximizing shareholder value. Stringer's financial acumen is essential for Probiotec's sustained success and its ability to serve blue-chip manufacturers and FMCG clients effectively.
Julie McIntosh - Chief Operating Officer
Julie McIntosh, the Chief Operating Officer at Probiotec, directs the operational execution and efficiency across the company's manufacturing, marketing, and distribution functions. McIntosh oversees the day-to-day activities of Probiotec's facilities in Laverton North, Victoria, ensuring the seamless delivery of prescription and over-the-counter pharmaceuticals and complementary medicines. This leadership role involves optimizing production processes for contract manufacturing and packaging services, supporting diverse industries such as food, personal care, and pharmaceuticals. Julie McIntosh ensures that Probiotec's subsidiaries, including Probiotec Pharma and Probiotec Multipack, operate at peak performance, providing specialized manufacturing and secondary packing for a variety of consumer goods. The Chief Operating Officer focuses on maintaining high standards of quality and innovation, leveraging advanced facilities and experienced personnel to meet the demands of blue-chip manufacturers and FMCG clients. McIntosh's operational oversight is fundamental to Probiotec's reputation for reliability and excellence.
Annalinde Nickisch - Chief People Officer
Annalinde Nickisch, the Chief People Officer at Probiotec, leads human capital strategy and organizational development for the Australian pharmaceutical and complementary medicines company. Nickisch is responsible for attracting, retaining, and developing the skilled workforce essential for Probiotec's operations, including its contract manufacturing and packaging services. This executive ensures a robust talent pipeline to support advanced facilities and experienced personnel across all departments, from manufacturing to distribution. Annalinde Nickisch cultivates a company culture that fosters innovation and quality, aligning with Probiotec's commitment to serving blue-chip manufacturers and FMCG clients. The Chief People Officer oversees employee relations, compensation, benefits, and performance management, ensuring compliance and promoting a productive work environment. Nickisch's strategic approach to human resources is vital for maintaining Probiotec's operational excellence and its capacity to deliver high-quality solutions.
Explore Leadership Teams in Manufacturing
Astellas Pharma is engaged in the manufacturing, marketing, import, and export of pharmaceuticals. It is headquartered in Tokyo, Japan.
Company Leadership
AD
MB
AR
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions.
Company Leadership
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies. Two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrows health challenges. We are Amneal and We make healthy possible.
Company Leadership
JS
Gland Pharma Limited is a rapidly growing global manufacturer of generic injectables, supplying to markets including the United States, Europe, Canada, Australia, and India. The company specializes in complex injectables, oncology, and ophthalmics, leveraging its robust R&D and manufacturing capabilities. Established in 1978 in Hyderabad, India, Gland Pharma has expanded its operations to over 60 countries, focusing on a business-to-business model. With a commitment to high-quality and affordable products, Gland Pharma aims to meet diverse injectable needs across the pharmaceutical industry.
Company Leadership RP
AW
RM
KR
Frequently Asked Questions Regarding Probiotec Top Executives and Leadership Team
